Innovating Works
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
HemaFAIR: Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 Research on rare diseases (RDs) is scarce and fragmented in the EU, leading to delayed diagnoses, limited availability of medicinal products...
2024-05-21 - 2027-06-30 | Financiado
ERAMET: Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the... FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un HORIZON EUROPE: HORIZON-HLTH-2023-IND-06 ERAMET will provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the dr...
2023-11-17 - 2027-12-31 | Financiado
EJP RD: European Joint Programme on Rare Diseases FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un H2020: H2020-SC1-BHC-2018-2020 As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado
ARISE: African Research and Innovative Initiative for Sickle cell Education Improving Research Capacity fo... FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS tramitó un H2020: H2020-MSCA-RISE-2018 The Overarching Objective for this consortium is to establish an inter-agency and multidisciplinary staff exchange programme between researc...
2018-10-26 - 2024-10-31 | Financiado
c4c: conect4children COllaborative Network for European Clinical Trials For Children FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un H2020: H2020-JTI-IMI2-2016-10-two-stage Paediatric medicines development is embedded in the European policy, legislation and in the work of the pharmaceutical industry but currentl...
2018-06-22 - 2025-04-30 | Financiado
ID-EPTRI: Infradev European Paediatric Translational Research Infrastructure FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un H2020: H2020-INFRADEV-2016-2017 The general objective of this project is to design the framework for the European Paediatric Translational Research Infrastructure (EPTRI),...
2018-01-25 - 2020-04-30 | Financiado
CLOSED: Clonidine for Sedation of Paediatric Patients in the Intensive Care Unit FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un FP7: The majority of critically ill children admitted to Paediatric Intensive Care Units (PICU) will require sedation and analgesia which is comm...
Financiado
DEEP: DEferiprone Evaluation in Paediatrics FONDAZIONE PER LA RICERCA FARMACOLOGICA GIANNI BENZI ONLUS participó en un FP7: β-thalassaemia major is one of the most severe forms of chronic congenital anaemia. The recommended treatment consists in regular blood tran...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.